Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
Clinical Pharmacokinetics|October 28, 2024
Changes in Plasma Clearance of CYP450 Probe Drugs May Not be Specific for Altered In Vivo Enzyme Activity Under (Patho)Physiological Conditions: How to Interpret Findings of Probe Cocktail StudiesLaura M de Jong, Marinda van de Kreeke, Mariam Ahmadi, et al.
European Urology|May 2, 2015
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinomaMeta H M Diekstra, Jesse J Swen, Epie Boven, et al.
Genes|December 3, 2020
Using Personal Genomic Data within Primary Care: A Bioinformatics Approach to PharmacogenomicsRick Overkleeft, Judith Tommel, Andrea W M Evers, et al.
Genes|November 30, 2018
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD VariantsCarin A T C Lunenburg, Linda M Henricks, André B P van Kuilenburg, et al.
Clinical Pharmacology and Therapeutics|May 1, 2019
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic TestingCathelijne H van der Wouden, Mandy H van Rhenen, Wafa O M Jama, et al.
European Journal of Clinical Pharmacology|September 22, 2015
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinomaMeta H M Diekstra, Xiaoyan Liu, Jesse J Swen, et al.
British Journal of Clinical Pharmacology|September 4, 2018
Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling deviceTom C Zwart, Sumit R M Gokoel, Paul J M van der Boog, et al.
The Pharmacogenomics Journal|January 25, 2017
Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinibJ S L Kloth, M C Verboom, J J Swen, et al.
British Journal of Clinical Pharmacology|August 6, 2024
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancerEline L Giraud, Stefanie D Krens, Stefan Böhringer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2022
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential MechanismSylvia D Klomp, Soufian Meziyerh, Maurits F J M Vissers, et al.
Pageof 19